Citadel Advisors

Citadel Advisors’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Citadel Advisors’s Portfolio EUCRU Stock Details EUCRU Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell
2021 Q4	$100K	Hold
2021 Q3	$101K	Sell
2021 Q2	$114K	Buy